Form 4: Astrana Health CEO Receives Stock Grant

Astrana Health CEO Brandon Sim was granted restricted stock units and acquired additional shares, impacting his beneficial ownership.

Summary

• Brandon Sim, CEO and President of Astrana Health, Inc., reported changes in beneficial ownership of the company's common stock on April 6, 2026.
• He received a grant of 201,056 restricted stock units (RSUs), which represent a contingent right to receive one share of common stock.
• These RSUs are scheduled to vest in eight equal semi-annual installments starting October 6, 2026, provided he remains employed.
• The filing also details other unvested restricted stock and RSUs with various vesting schedules throughout 2026.
• Additionally, 1,420 shares were acquired under the company's Employee Stock Purchase Plan.
• Certain securities are held indirectly through the Sim Family Irrevocable Trust 2021 and the Brandon Sim 2020 Irrevocable Trust, with Sim disclaiming beneficial ownership beyond his pecuniary interest.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it primarily reports on routine executive compensation and ownership changes rather than significant financial performance or strategic shifts.

Positives

• Grant of restricted stock units (201,056) indicates a long-term incentive and retention strategy for the CEO.
• Vesting schedules for RSUs and restricted stock align with continued employment, promoting executive commitment.
• Acquisition of shares through the Employee Stock Purchase Plan (1,420 shares) shows employee participation in ownership.

Negatives

• The filing details a complex structure of indirect beneficial ownership through trusts, which can sometimes obscure direct control or intent.
• The disclaimer of beneficial ownership for trust-held securities, except for pecuniary interest, may be a point of scrutiny for some investors.

Risks

• Vesting of restricted stock and RSUs is contingent upon continuous employment with the Issuer, posing a risk of forfeiture if employment ceases.
• The disclaimer of beneficial ownership for trust-held securities could lead to questions about ultimate control and responsibility.
• Market volatility could impact the value of the granted and held securities.

Future Outlook

The future outlook is tied to the vesting of restricted stock and RSUs, which are contingent upon continued employment with Astrana Health, Inc. The vesting schedules extend into late 2026 and beyond, indicating a long-term commitment from management.

Management Comments

• The Reporting Person disclaims beneficial ownership of securities held by the Sim Family Irrevocable Trust 2021 and the Brandon Sim 2020 Irrevocable Trust, except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Industry Context

StockSavvy.ai notes that grants of restricted stock units and restricted stock to senior executives are a common practice in the health technology sector to align executive interests with shareholder value and to incentivize long-term performance and retention.

Stakeholder Impact

• Shareholders: The grant of RSUs and restricted stock to the CEO, with vesting tied to employment, aligns executive incentives with long-term company performance and value creation.
• Employees: The acquisition of shares through the Employee Stock Purchase Plan indicates continued employee engagement and investment in the company.
• Management: The reporting person's beneficial ownership structure, including indirect holdings through trusts and disclaimers, is a standard aspect of executive compensation and personal financial planning.

Next Steps

• Continued employment with Astrana Health, Inc. to meet vesting requirements for restricted stock and RSUs.
• Monitoring of vesting schedules for granted and held equity awards.

Key Dates

Keywords

Form 4, SEC Filing, Insider Trading, Beneficial Ownership, Stock Grant, Restricted Stock Units, Vesting Schedule, Astrana Health, ASTH, Brandon Sim, CEO, Employee Stock Purchase Plan, Irrevocable Trust